Cyclooxygenase inhibitors and cancer: the missing pieces
C Patrono - Journal of Pharmacology and Experimental …, 2023 - ASPET
At 125, aspirin still represents the cornerstone of anti-platelet therapy for the acute treatment
and long-term prevention of atherothrombosis. The development of a selective regimen of …
and long-term prevention of atherothrombosis. The development of a selective regimen of …
Cyclooxygenase Inhibitors and Cancer: The Missing Pieces
C Patrono - The Journal of pharmacology and …, 2023 - pubmed.ncbi.nlm.nih.gov
At 125, aspirin still represents the cornerstone of anti-platelet therapy for the acute treatment
and long-term prevention of atherothrombosis. The development of a selective regimen of …
and long-term prevention of atherothrombosis. The development of a selective regimen of …
[引用][C] Cyclooxygenase Inhibitors and Cancer: the Missing Pieces
C Patrono - Journal of pharmacology and experimental … - cochranelibrary.com
Cyclooxygenase Inhibitors and Cancer: The Missing Pieces.
C Patrono - The Journal of Pharmacology and Experimental …, 2023 - europepmc.org
At 125, aspirin still represents the cornerstone of anti-platelet therapy for the acute treatment
and long-term prevention of atherothrombosis. The development of a selective regimen of …
and long-term prevention of atherothrombosis. The development of a selective regimen of …
Cyclooxygenase Inhibitors and Cancer: The Missing Pieces
C Patrono - Journal of Pharmacology and Experimental …, 2023 - ASPET
At 125, aspirin still represents the cornerstone of anti-platelet therapy for the acute treatment
and long-term prevention of atherothrombosis. The development of a selective regimen of …
and long-term prevention of atherothrombosis. The development of a selective regimen of …